The answer depends on the specific medication and exposure
My logic was wrong and what I was doing was stupid
If symptoms persist beyond two to four weeks at a stable dose or are severely affecting daily life, contact your prescriber
Common symptoms include: Persistent facial redness Flushing that lasts longer than normal Visible blood vessels (broken capillaries) Acne-like bumps Burning, stinging, or itching sensations Other, less common symptoms may include: Swollen or thickened skin Dry, irritated eyes or eyelids Sensitivity to skincare products or environmental factors If youre noticing any of these symptoms, especially facial redness that doesnt fade, it might be time to speak to your doctor
If results remain strong across the program, many analysts expect retatrutide to become one of the most commercially significant peptide therapeutics ever developed
According to the brand's published FAQ, GLP BodyGuard supports tracking alongside semaglutide (including Ozempic and Wegovy), tirzepatide (including Mounjaro and Zepbound), liraglutide, and what the brand describes as "emerging dual/triple agonists." The brand states: "We never tell you what to take - that's between you and your physician." The platform's tracking features are habit-based and composition-focused, not medication management tools